InvestSMART

MGC Pharmaceuticals Ltd (ASX: MXC) - Announcements

Current share price for MXC : $0.420 0.01 (2.44%)+

ASX company news and announcements for MGC Pharmaceuticals Ltd (MXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MGC Pharmaceuticals Ltd (MXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MGC Pharmaceuticals Ltd (MXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MGC Pharmaceuticals Ltd (MXC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Change of Director's Interest Notice - Appendix 3Y x 2 23 Mar 2020 4:46PM $0.017 $0.420 risen by 2,370.59%
$18 Suspension from Official Quotation 23 Mar 2020 10:15AM $0.017 $0.420 risen by 2,370.59%
$18 Trading Halt 19 Mar 2020 9:53AM $0.017 $0.420 risen by 2,370.59%
$18 SPP - Appendix 2A 17 Mar 2020 5:22PM $0.017 $0.420 risen by 2,370.59%
$18 Operational Update and Share Purchase Plan Completion 16 Mar 2020 7:35PM $0.020 $0.420 risen by 2,000%
$18 Patients Begin Treatment in Clinical Trial of CogniCann 9 Mar 2020 9:45AM $0.025 $0.420 risen by 1,580%
$18 Extension of SPP Closing Date 3 Mar 2020 2:52PM $0.028 $0.420 risen by 1,400%
$18 Binding Amendment to Supply Agreement with ONIX Brazil 3 Mar 2020 9:52AM $0.025 $0.420 risen by 1,580%
$18 Half Yearly Report and Accounts 28 Feb 2020 3:02PM $0.025 $0.420 risen by 1,580%
$18 Trading Halt 28 Feb 2020 9:23AM $0.025 $0.420 risen by 1,580%
$18 Notice Under Section 708A(5)(e) of the Corporations Act 27 Feb 2020 2:05PM $0.025 $0.420 risen by 1,580%
$18 Commercial Supply Deal Signed for First Products into Poland 26 Feb 2020 11:55AM $0.026 $0.420 risen by 1,515.38%
$18 Completion of $1m Placement - Appendix 2A 25 Feb 2020 12:36PM $0.026 $0.420 risen by 1,515.38%
$18 85% Increase in Order Volume of New Prescription Products 21 Feb 2020 9:22AM $0.027 $0.420 risen by 1,455.56%
$18 SPP Offer Document and Application Forms Despatched 20 Feb 2020 9:48AM $0.027 $0.420 risen by 1,455.56%
$18 Security Purchase Plan- Offer Document 17 Feb 2020 10:45AM $0.029 $0.420 risen by 1,348.28%
$18 Notice Under Section 708A(5)(e) of the Corporations Act 17 Feb 2020 10:25AM $0.030 $0.420 risen by 1,300%
$18 Proposed issue of Securities - MXC 17 Feb 2020 9:57AM $0.032 $0.420 risen by 1,212.50%
$18 MGC Pharma announces $1m Strategic Placement and $3m SPP 17 Feb 2020 9:56AM $0.032 $0.420 risen by 1,212.50%
$18 Trading Halt 13 Feb 2020 9:15AM $0.032 $0.420 risen by 1,212.50%
$18 December Quarterly Activity and Cashflow Report 31 Jan 2020 12:15PM $0.035 $0.420 risen by 1,100%
$18 Agreement Signed with Leading Peruvian Distributor 28 Jan 2020 9:51AM $0.035 $0.420 risen by 1,100%
$18 THC: Product Supply Agreement Signed with MGC Pharma 20 Jan 2020 9:36AM $0.037 $0.420 risen by 1,035.14%
$18 Supply Agreement with THC Global for Canndeo Products 20 Jan 2020 9:27AM $0.037 $0.420 risen by 1,035.14%
$18 Company Presentation for UK and Australian Investors 17 Jan 2020 9:04AM $0.038 $0.420 risen by 1,005.26%

476 - 500 of 818 results

Page 20 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.